Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,896,875

« Back to Dashboard

Title: Mixable combination for generating a suspension of stable microbubbles for ultrasonic imaging
Abstract:Gas or air filled microbubble suspensions in aqueous phases usable as imaging contrast agents in ultrasonic echography. They contain laminarized surfactants and, optionally, hydrophilic stabilizers. The laminarized surfactants can be in the form of liposomes. The suspensions are obtained by exposing the laminarized surfactants to air or a gas before or after admixing with an aqueous phase.
Inventor(s): Schneider; Michel (Troinex, CH), Yan; Feng (Carouge, CH), Grenier; Pascal (late of Ambilly, FR), Garcel; Nadine (Ambilly, FR), Puginier; Jerome (Le Chable-Beaumont, FR), Barrau; Marie-Bernadette (Geneve, CH), Bussat; Philippe (Feigeres, FR), Hybl; Eva (Heidelberg, DE), Bichon; Daniel (Montpellier, FR)
Assignee: Bracco International B.V. (Amsterdam, NL)
Filing Date:Aug 23, 2002
Application Number:10/226,244
Claims:1. A mixable combination for generating a suspension of stable microbubbles for use in ultrasonic imaging, said combination comprising: (a) a dry pulverulent formulation comprising at least one film forming surfactant and a hydrophilic stabilizer in the presence of an entrappable gas comprising freon, the film forming surfactant being a saturated phospholipid in lamelar or laminar form and capable of generating a suspension of stabilized gas microbubbles when brought into contact with an aqueous carrier phase; and (b) an aqueous carrier phase mixable with said dry formulation, said dry formulation and said aqueous carrier phase being mixable with each other to produce said suspension of stable microbubbles.

2. The mixable combination of claim 1, wherein the entrappable gas is a mixture of freon with nitrogen.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.